The Technical AnalystExchange: JKT Sector: Healthcare Industry: Medical Care Facilities
PT Siloam International Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.40% IDR2 510.00
America/New_York / 3 mai 2024 @ 05:06
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 32 585 372 mill |
| EPS: | 74.84 |
| P/E: | 33.54 |
| Earnings Date: | Apr 26, 2024 |
| SharesOutstanding: | 12 982 mill |
| Avg Daily Volume: | 2.86 mill |
| RATING 2024-05-03 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.51x |
| Company: PE 33.54 | sector: PE 65.62 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.24x |
| Company: PE 33.54 | industry: PE 140.91 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
IDR5 783.27 (130.41%) IDR3 273.27 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
IDR 2 417.38 - 2 602.62 ( +/- 3.69%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | IDR2 510.00 (-0.40% ) |
| Volume | 4.07 mill |
| Avg. Vol. | 2.86 mill |
| % of Avg. Vol | 142.41 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SILO.JK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SILO.JK
PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia. It also engages in setting up and managing hospitals. The company offers specialist and general medical services, including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services. Its hospitals provide services in the areas of pediatrics, neurology, ENT, general surgery, emergency, nephrology, cardiology, oncology, obstetrics and gynecology, gastroenterology, ophthalmology, pulmonology, internal medicines, orthopedics, urology, anesthesiology, dentistry, dermatology, geriatric and nuclear medicines, pathology, plastic surgery, and psychiatry. The company operates 40 hospitals with 8,450 beds in Sumatra, Java, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka. In addition, it engages in trading, development, mining, agriculture, service, land transportation, industry, workshop printing, plantation, forestry, electrical, mechanical, engineering, construction, agribusiness, and real estate businesses; computer programming activities; provision of management consulting, trust, financing, financial entities, retail, professional, and scientific and technical activities; and web portal and/or digital platform business. The company was formerly known as PT Sentralindo Wirasta. PT Siloam International Hospitals Tbk was founded in 1996 and is headquartered in Tangerang, Indonesia.